At a Glance
Compound is a venture capital firm based in San Francisco, CA founded in 2022. Compound is a thesis-driven, research-centric investment firm The firm focuses on Seed, Series A investments across sectors including AI, Biotech. Contrarian n-of-1 investor backing breakthrough companies across frontier sectors including AI and biotech.
“Contrarian n-of-1 investor backing breakthrough companies across frontier sectors including AI and biotech.”
Compound primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
Compound is headquartered in San Francisco, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Compound focuses on investments in AI, Biotech. Their portfolio reflects deep expertise and networks within these sectors.
Compound's typical investment check size ranges from $400K to $1.5M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Compound manages approximately $85M in assets under management (AUM) across their funds.
